What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%



Code Company Date Close Change Indicator Value Signal

Trading Performance

Williams %R



Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 40 10.6 0.65% 1.73% 5.5% -5.1% 64.8%
SHORT 39 9.8 0.62% 1.26% 4.0% -9.2% -77.8%


Technical Analysis

Opthea (OPT.AX)



Last Signal:


Trading: SELL @ $3.32
Signal Strength: STRONG

Indicator is best used in conjunction with additional indicators as it has the ability to highlight potential overbought or oversold levels. This indicator utilizes upper and lower bands to visually represent price extremes associated with the bands. Additional value can be added to the trading strategy by accessing divergences between price and volume.

Opthea (ASX:OPT) is currently Overbought highlighting the potential for a short term trend reversal in the downward direction.

Developed by Larry Williams, Williams %R is a momentum indicator that is the inverse of the Fast Stochastic Oscillator. Also referred to as %R Williams %R reflects the level of the close relative to the highest high for the look-back period.

Calculation: Williams %R:
1) %R = (Highest High - Close)/(Highest High - Lowest Low) * -100;
2) Lowest Low = lowest low for the look-back period Highest High = highest high for the look-back period %R is multiplied by -100 correct the inversion and move the decimal;


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

Williams %R

Company Close Change(%) Volume Value Signal
IEL IDP Education 22.72 2.1 736,761 26.9 BULLISH CROSSOVER
FBR Fastbrick Robotics 0.05 1.9 391,995 46.2 BULLISH CROSSOVER
CWN Crown 11.8 0.2 982,395 25.7 BULLISH CROSSOVER
FID Fiducian 6 0 24,363 35.5 BULLISH CROSSOVER
PMV Premier Investments 20.77 0 124,816 31.2 BULLISH CROSSOVER
PRU Perseus Mining 1.17 0 1,800,051 38.5 BULLISH CROSSOVER
SYD Sydney Airport 8.39 -0.1 8,609,434 44.8 BULLISH CROSSOVER
TCL Transurban 16.16 -0.1 3,069,833 27.5 BULLISH CROSSOVER
XNJ ASX 200 Industrials 7135.5 -0.6 0 39.2 BULLISH CROSSOVER
XSO ASX Small Ordinaries 3032.4 -0.6 0 35.4 BULLISH CROSSOVER